🚨 Call for Abstracts Now Open #NDLR2026 🚨 Only 3 weeks left to submit your abstracts! 🗓 Submission closes 23/09/2025 🩸 Submit now: https://t.co/NF7po9GDcq 🎟️ Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer

🚀 #NDLR2026 is proud to announce its full scientific program! Join us for an unmissable gathering of global leaders sharing the latest breakthroughs in blood cancer research! #BloodCancerResearch #MPN #Myeloma #ALL #AML #Lymphoma #MDS #PediatricLeukemia #SpatialProfiling #CML

We’re thrilled to welcome #NDLR2026 speaker Anna Steiner, a passionate advocate for #MPN and #BloodCancer research, support, and prevention. Anna's focus is on improving regional equity in diagnosis, treatment, and clinical trial access.

🚨 LAST CHANCE to submit your abstract. Submission closes today 7 October 2025 🚨 An exciting #NDLR2026 lineup of invited international and national speakers has been announced. Submit now: https://t.co/4iF0oCO95P #BloodCancer #CancerResearch #ChildhoodCancer

🚨 Submit your abstract by 7 October 2025. Only 1 week left! 🚨 An exciting #NDLR2026 lineup of invited international and national speakers has been announced. 🗓 Submission closes 07/10/2025 🩸 Submit now: https://t.co/NF7po9GDcq #BloodCancer #CancerResearch #ChildhoodCancer

We are thrilled to announce #NDLR2026 speaker Dr @Cavanbennett postdoctoral researcher @WEHI_research. Cavan's research focuses on #haematology particular the effects of iron in #MyeloproliferativeNeoplasms. #BloodCancer #CancerResearch

We are excited to announce #NDLR2026 speaker Chelsea Mayho from the Childrens Cancer Institute.  Chelsea is working on developing #Bioinformatics pipelines for the #ZeroChildhoodCancer Program #ClinicalTrials, including the development of a #DrugDiscovery pipeline. #Leukemia

We are thrilled to announce #NDLR2026 speaker Dr Julie Thoms, from @UNSW . Julie's research interests lie in understanding #GeneRegulation in #Leukemia driving stem cells to develop #TargetedTherapies. #BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia

We are excited to announce #NDLR2026 speaker Prof Hamish Scott, from @SAPathology. Hamish's #CancerResearch is on identifying #BloodCancer #Genetics for the use in #PersonalizedMedicine.

🚨 Call for Abstracts Now Open #NDLR2026 🚨 Only 1 week left to submit your abstracts! 🗓 Abstract submission closes 23 September 2025 🩸 Submit now: https://t.co/NF7po9GDcq

We are excited to announce #NDLR2026 speaker, Assoc Prof @LevKats from @PeterMacCC. Lev's research includes #Epigenetic regulation, #Metabolism and #TargetedTherapies. His lab uses molecular and functional #Genomics to develop new treatment strategies for aggressive #BloodCancer

We are thrilled to introduce our new #NDLR2026 Meet-the-Editor session, with esteemed Editors-in-Chief, Prof. Andrew Roberts Roberts from Blood and Prof. Jan Cools, @Hemasphere_EHA who will share their invaluable insights on publishing in high-impact hematology journals.

We are thrilled to announce Prof Eliza Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia

We are excited to introduce #NDLR2026 speaker Dr Jennifer Devlin, one of from @PeterMacCC. Jennifer’s research focuses on dissecting the molecular mechanisms that control #GeneExpression to identify transcriptional vulnerabilities that may be exploited for #CancerTreatment.

We are honoured to welcome clinician-scientist Prof @StevenLane_QIMR from @QIMRB_Institute as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.

We are thrilled to announce that Associate Professor @juliamaxson from @OHSUKnight Cancer Institute, USA, will be joining us at #NDLR2026. Julia's research focuses on investigating the cellular and molecular changes that cause myeloid #Leukemia.

Exciting News! Prof. Jan Cools, KU Leuven, Editor-in-Chief of @Hemasphere_EHA, is speaking at #NDLR2026. Jan researches #TumorHeterogeneity, transcription factor deregulation and constitutive kinase signaling of acute lymphoblastic #leukemia using #Omics.

We are honoured to welcome Professor John D. Crispino, from @StJude as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.

A huge thank you to @LeukaemiaAus for sponsoring NDLR 2026!